This study aimed to identify potential knowledge-performance gaps in antibiotic prescribing for bacterial isolates in the Intensive Care Unit (ICU) in order to guide the development of interventions such as antibiotic policies, decision support, and improved systems for communication between the laboratory and the bedside. A prospective observational cohort study of all patients admitted to a mixed medical/surgical ICU was undertaken over a sixmonth period in an Australian adult tertiary hospital. From a cohort of 524 patients, 108 had 303 isolates that were eligible for inclusion. Overall, 14.3% and 30.8% of sterile and non-sterile isolates respectively were associated with inadequate initial antibiotic therapy after identification of the bacteria. After sensitivity results were available inadequate directed therapy was observed in 4.0% and 21.3% of sterile and non-sterile isolates respectively. Problems were most commonly associated with isolates of Pseudomonas spp., Stenotrophomonas spp., Acinetobacter spp., S. aureus, enterococci and group III Enterobacteriaceae. Inadequate antibiotic therapy was found to be independently associated with prolonged length of ICU stay. Narrower spectrum antibiotic therapy was potentially available for 30% of isolates after sensitivity results were known. We conclude that there is scope to improve antibiotic prescribing in the ICU by providing clinicians with access to information regarding local susceptibility patterns and intrinsic resistance of bacteria, and spectra of antibiotic cover. Timely notification of laboratory results at the point of care may also facilitate improved prescribing performance.
Approximately 20% of patients admitted to an intensive care unit (ICU) either have or will develop an infection, and of these, up to 50% are associated with severe sepsis or shock 1, 2 . Broad-spectrum empiric antibiotics are often initiated for these patients on clinical grounds to cover multiresistant organisms found in the clinical environment of the ICU, as inadequate empiric therapy has been associated with increased patient mortality [3] [4] [5] . These choices must be balanced with the knowledge that broad-spectrum antibiotics inevitably apply selection pressure upon local fl ora that may exacerbate future microbial antibiotic resistance in the hospital and especially the ICU environment 6, 7 . To combat these undesirable effects, rational empiric antibiotic use should be based upon the expected sensitivity patterns of isolates within the unit (the local 'antibiogram'), with prompt adjustment to directed therapy targeting pathogens as they are confi rmed microbiologically [8] [9] [10] [11] . Appropriate prescribing, therefore, depends upon access to information. This study aimed to review antibiotic use associated with bacterial isolates in an adult medical and surgical ICU of an Australian tertiary hospital to identify areas where antibiotic choices differed from what might have been recommended, based upon available microbiological information. We aimed to identify areas where interventions can be focused to improve prescribing behaviour.
METHOD

Setting
The Royal Melbourne Hospital is a 380-bed tertiary referral centre with a 21-bed adult ICU for trauma, surgical and medical patients. This study was a prospective survey of all patients admitted to the unit from 1 June 2000 to 30 November 2000 .
Baseline data
A dedicated research nurse recorded baseline demographic information for each patient admitted to ICU including age, sex, APACHE II score at 24 hours post-admission, known drug allergies and admission type (surgical/medical). Information was collected from the pathology database regarding all bacterial isolates obtained from these patients during their admission. In particular, data were collected on the date and time of release of isolate identifi cation, date and time of release of antimicrobial susceptibility results from the laboratory, and the full antibiotic susceptibility profi le. Concurrently, the ICU pharmacist recorded prospectively the time of initiation and duration of all antibiotics pre scribed for each patient.
The reason for initially prescribing any antibiotics was recorded as surgical prophylaxis, suspected infection or documented in fection. Suspected infection in the absence of an identifi ed isolate required that the patient fulfi lled the Systemic Infl ammatory Response Syndrome (SIRS) Criteria 12 . For patients with a respiratory, blood or wound swab isolate obtained >48 hours after hospitalization, we attempted to differentiate between colonization and infection by applying the National Nosocomial Infections Surveillance (NNIS) criteria for nosocomial infections 13 . Consistency and accuracy of this classifi cation was checked by an infectious diseases physician (NB, KT) by reviewing a sample of patients from the study and comparing classifi cations with those of the research nurse.
The treating clinicians were not consulted, to avoid potential infl uence upon their prescribing patterns. There were no unit antibiotic guidelines or restrictive antibiotic policies in use at the time of this study, and antibiotic prescriptions were at the discretion of the treating clinician. Data were collected from the date of admission until the date of discharge from ICU, or death. The study was conducted in accord with the ethics requirements for quality assurance projects at the hospital.
Data interpretation
The study was designed to assess the timeliness and adequacy of antibiotic therapy in response to positive bacterial cultures. At this hospital, bacterial identifi cation (by positive direct examination or positive culture) was released separately to full sensitivity results (the median delay being 24 hours). A number of outcome measures were defi ned for the purposes of the analysis. Untreated isolates were defi ned as isolates that were not associated with any antibiotic therapy from date of organism identifi cation to seven days after the release of sensitivity results. Inadequate initial therapy refers to the antibiotics used after organism identifi cation but before sensitivity results were known. Inadequate initial therapy was defi ned as antibiotic therapy that would not be expected to cover the isolate, using predictions based on the unit antibiogram. Inadequate directed therapy was defi ned as antibiotic therapy that did not cover the isolate once SR were known. Delayed onset of therapy was defi ned as adequate antibiotic therapy that was commenced greater than 24 hours after the organism identifi cation or sensitivity results were known. A composite measure of overall antibiotic adequacy was created (any inadequate) and this included sterile and non-sterile site isolates associated with inadequate initial or directed therapy, as well as untreated sterile site isolates.
Analysis was restricted to organisms identifi ed after admission to the intensive care unit and before discharge or death. All isolates from sterile sites (blood, cerebrospinal fl uid, and other sterile fl uids) were assessed individually, unless the same organism with the same sensitivity pattern was isolated from the same site within 24 hours, in which case that isolate was included once only. Similarly, isolates from non-sterile sites were included only once if the same organism with the same sensitivity profi le was isolated from the same site within a three-day period. Toxin and serology results were not included in this analysis.
An antibiogram created from isolates obtained in this ICU over the preceding six months was used to predict the appropriateness of initial therapy. Initial therapy was considered adequate if >75% of previous isolates of a given species were susceptible to the antibiotic used. The researchers also utilized information on antibiotic spectra and intrinsic re sistances of pathogens from widely available resources 33 . Where multiple antibiotics were used, therapy was adequate if any one of the agents covered the organism. Dual cover for organisms such as Pseudomonas was not deemed necessary for the purposes of this study, although aminoglycoside monotherapy was considered suboptimal for the treatment of Pseudomonas spp. or beta-lactamase inducible gram negatives in sterile site or respiratory specimens. When assessing for narrower spectrum antibiotics, the hierarchy of antibiotic spectrum was; narrow spectrum penicillins and gentamicin <fi rst, second then third generation cephalosporins <antipseudomonal third generation cephalosporins and broad-spectrum penicillins <quinolones and carbapenems.
Antibiotic allergies were recorded, and were taken in to account when assessing appropriateness of therapy.
Three infectious disease physicians generated rules to standardize the interpretation of the results (AS, NB, KT), and sought peer review of these rules from infectious diseases physicians not involved as primary researchers.
Data Analysis
A descriptive analysis of patient characteristics was performed, with differences between proportions assessed using Fisher's exact test. The impact of inadequate antibiotic cover on length of stay was evaluated by negative binomial regression (rather than Poisson regression to account for additional dispersion), retaining those variables with P<0.05. Variables were chosen a priori if they were likely to be risk factors for prolonged length of stay or increased mortality. Stata software (version 7) 14 was used for statistical analysis.
RESULTS
There were 524 patients and 2209 occupied ICU bed-days during the study period. The patient characteristics are shown in Table 1 . Sixty-six percent of ICU patients received antibiotics during their admission, with a median of 3 antibiotics per patient (range 1 to 11). Of these, 55% received antibiotics within 24 hours of admission. The antibiotic prescribed most often was vancomycin, followed by imipenem and ceftriaxone. Seventy-three percent of patients receiving antibiotics had them initiated for suspected infection in the absence of positive microbiology, and 31% of these patients subsequently had positive cultures. The median duration in the absence of positive cultures was three days (range 1-27) compared to eight days (1-55) in patients with positive microbiology. Intubated patients were more likely than non-intubated patients to have positive cultures (29% vs 6%, P<0.001) and to receive antibiotics (79% vs 55%, P<0.001). Ninety-two percent of bacterial isolates came from specimens taken >48 hours after the patient had been admitted to hospital (likely to be nosocomially acquired).
Microbiology
Three-hundred-and-three bacterial isolates from 108 patients were included in the analysis. Isolates from non-sterile sites accounted for 80% while the remaining 20% of isolates were from sterile sites. Respiratory specimens accounted for 60% of all isolates included in the analysis. Sterile isolates included 40 blood cultures, 18 sterile fl uids (pleural or peritoneal or joint fl uids) and 3 cerebrospinal fl uid (CSF) isolates. Thirty-three percent of respiratory isolates and 56% of other non-sterile site (e.g. wound swab) isolates were not associated with a nosocomial infection (by NNIS criteria).
Staphylococcus aureus was the most common isolate (38.3%), of which 78.4% were methicillin resistant (MRSA). The median time to acquisition of MRSA was 7.5 days after admission to ICU. Group III Enterobacteriaceae (Enterobacter spp., Serratia spp., Citrobacter spp) and Acinetobacter spp. accounted for 38% of all gram-negative isolates. The median time to acquisition of these species of bacteria was 6.5 days. Other isolates in decreasing order of frequency were Pseudomonas spp., Escherichia coli, coagulase negative staphylococci (CNS), enterococcus spp., and Stenotrophomonas maltophilia. Only four of the evaluated isolates came from patients whose indication for antibiotic therapy was prophylaxis. All other isolates were from patients who fi tted the criteria for SIRS, or had documented infection at the time of admission to ICU. Ninety-one per cent of patients with isolates (98/ 108) fulfi lled the diagnostic criteria for at least one nosocomial infection: ventilatorassociated pneumonia (66), bloodstream infection (32) , and wound infection (18) . Table 2 describes the adequacy of antibiotic therapy associated with the predominant isolates. Few isolates remained untreated. Initial antibiotic therapy was effective against 69.2 % of non-sterile isolates and 85.7% of sterile isolates. The three untreated sterile isolates in this cohort were a Klebsiella spp., Burkholderia spp. and coagulase negative staphylococci, each from a sterile fl uid. Of the eight sterile isolates with inadequate initial therapy, fi ve were due to failure to use empiric glycopeptides for S. aureus (4) and CNS (1) bacteraemias.
Adequacy of antibiotic coverage
In general, prescribing for gram positive isolates was better than for gram negative isolates. The highest rates (>40%) of inadequate initial antibiotic coverage were observed for Group III Enterobacteriaceae, enterococci spp., Acinetobacter spp., and Stenotrophomonas spp. As directed therapy, broad-spectrum penicillins and cephalosporins were often used for gram negative bacilli with inducible beta lactamases despite a warning on the microbiology report advising against this (40% of the Group II Enterobacteriaceae associated with any directed therapy, were receiving cephalosporins). A failure to broaden cover in response to release of SR for some resistant isolates of enterocci and Acinetobacter spp. was noted.
Timeliness
For those patients not already receiving adequate antibiotic cover, an appropriate antibiotic was commenced within 24 hours of identifi cation of the bacteria for 84% (40/48) of isolates. Where the initial cover was not adequate in light of sensitivity results, an adjustment to adequate therapy within 24 hours of release of sensitivity results occurred for 49% (15/31) of isolates. That is, adjustments to therapy were more likely to be prompt in response to bacterial organism identifi cation compared to release of sensitivity results (P=0.008).
Use of narrow spectrum antibiotics
Of those on an antibiotic that covered the organism, potential opportunity to use a narrower spectrum antibiotic choice was available for 30% of isolates after the release of sensitivity results. This is in addition to modifi cations in prescriptions already observed. Frequent use of quinolones and carbapenems was seen for gram negative organisms, despite sensitivity to penicillins, cephalosporins or aminoglycosides having been demonstrated. There were seven instances in which vancomycin was continued for methicillin sensitive Staphylococcus aureus (MSSA) in the absence of a documented beta-lactam allergy.
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Effect of inadequate antibiotic therapy on length of ICU stay and death in ICU
On univariate analysis, excluding patients who died, longer length of stay in ICU was associated with intubation (Risk ratio (RR) 2.52, 95% CI 2.14-3.08, P<0.001), presence of positive microbiology (RR 4.90, 95% CI 4.18-5.74, P<0.001), antibiotic use for documented infection (RR 4.00, 95% CI 3.29-4.87, P<0.001), APACHE II score (RR 1.07, 95% CI 1.05-1.08, P<0.001), any inadequate antibiotic therapy for sterile or non-sterile isolates (RR 4.39, 95% CI 3.55-5.43, P<0.001) and inadequate therapy for sterile isolates only (RR 1.99, 95% CI 1.66-3.41, P<0.012).
On multivariate analysis adjusting for these factors as well as age and sex, the effect of inadequate antibiotic therapy for any isolate had an independent association with prolonged length of stay (RR 1.34, 95% CI 1.05-1.72) (See Table 4 ). This observation was also seen when inadequate therapy for sterile isolates rather than all isolates was included in the model (RR 2.27, 95% CI 1.78-2.88, P=0.00). In a separate regression model, any inadequate antibiotic therapy was not found to be independently associated with death in ICU or 30 day mortality. In a multiple logistic regression model, the relative risk of death in ICU was signifi cantly associated with intubation (RR 1.14 95% CI 1.08-1.20) and APACHE II score (RR 1.01, 95% CI 1.007-1.015), but not inadequate antibiotic therapy at any time (RR 0.94, 95% CI 0.87-1.01).
DISCUSSION
This study provides a description of the bacterial isolates encountered, and the antibiotic prescribing patterns of clinicians in an intensive care unit from an Australian tertiary hospital. We found that most patients with bacterial isolates received antibiotic therapy, and importantly, isolates from sterile sites were usually adequately covered. Despite this, problems were identifi ed with the initial antibiotic choices for certain organisms, which were similar to those identifi ed in previous studies as the bacteria for which inadequate therapy was most often prescribed 29, 30 . This highlights an area where education may need to be focused, and information provided.
Delays in modifi cation of therapy in response to laboratory data were observed, and opportunities for de-escalation to narrower spectrum antibiotics were not always acted upon. In some cases this may be due to a delay in "following up" lab results in a busy working environment, and it is likely that improved communication systems would facilitate improved responses in prescribing practices. In this ICU, it was usual for the medical microbiologist to alert clinicians to positive blood culture results by telephone, which provided in addition a potential opportunity to discuss initial antibiotic selection. This direct notifi cation may have contributed to the more appropriate antibiotic choices made for the sterile site isolates. For nonsterile site specimens, the ICU medical staff instead had to regularly search for microbiology results on a pathology database. It has, however, been observed that intensivists place less importance on in vitro sensitivity data, and are less likely to use microbiology databases compared to the infectious diseases physician 31, 32 . The spectrum of antibiotics used during this study differs substantially from that previously described in Australian ICUs 12 . To some extent this may be due to exclusion of post cardiothoracic surgery patients, where antibiotic use for "extended prophylaxis" is often reported. Differences in the spectrum of pathogens encountered in different ICUs are also likely to account for prescribing differences.
We recognize that the bulk of antibiotic prescribing in the ICU occurs empirically, in the absence of bacterial isolates 27, 28 . This study focuses on just a ANTIBIOTIC PRESCRIPTION IN ICU proportion of all ICU patients, however it is a group in which auditing of prescribing practice is, to a limited extent, possible. Efforts to limit the use of broad spectrum antibiotics by using the unit antibiogram and targeting therapy to known pathogens are likely to impact beyond this specifi c group of patients, and infl uence antibiotic choices made for patients without bacterial isolates too. This was primarily a microbiologically based investigation and detailed information about the patient's clinical condition was not recorded. In some cases, the isolate examined may not have represented the only clinical problem for which antibiotics were being administered, (e.g. an E.coli isolated from urine of a patient being treated for suspected pneumonia). In these cases, broad spectrum antibiotics may have been appropriate to treat the suspected infection, regardless of the sensitivity profi le of an unrelated isolate. In contrast, the study may have over-emphasised the need to treat isolates that were considered on clinical grounds to be contaminants rather than pathogens (e.g. S. aureus isolated from tracheal aspirates). The use of NNIS criteria to attempt to separate infection from colonization is an attempt to minimize this problem, but does not overcome it completely.
Antibiotic prescribing in the intensive care unit is complex. On one hand there is accumulating evidence that inadequate empirical therapy is associated with increased mortality [16] [17] [18] [19] [20] [21] [22] . Therefore, commencing broad spectrum antibiotic therapy for suspected or documented sepsis is justifi ed in severely ill patients until isolates or sensitivities are known. On the other hand, there is the inherent danger of emerging antimicrobial resistance in the setting of excessive use of broad spectrum antibiotics 6, [23] [24] [25] . The strategy of de-escalation to narrower spectrum antibiotics, and reducing the duration of therapy is likely to be the best approach for reducing the use of broad spectrum antibiotics and thus decreasing selection pressure for antimicrobial resistance 26 . Ongoing active surveillance of the prescribing patterns of clinicians, and regular review of the antibiotic sensitivity profi les of bacteria within an ICU are important components of an effective infection control program 11 .
This study highlighted an opportunity to improve communication between the microbiology laboratory and the clinician. Initiatives such as a computerized 'real time' browser, or hand-held computers may improve access to data and facilitate appropriate responses in antibiotic prescribing. In some cases, incomplete knowledge rather than a lack of time may have been the major problem. Access to a local 'antibiogram' information on intrinsic resistance patterns of bac teria, and antibiotic spectra may be useful at the point of prescribing. Evolving technologies may allow clinicians to integrate this information to improve their decision making at the bedside, and further study in this area is required [33] [34] [35] .
This audit demonstrated potential problems with antibiotic prescribing in ICU for certain bacterial isolates. This highlights areas where education may be focused to improve practice. We suggest that better access to information on local epidemiology of pathogens and actual laboratory results might improve antibiotic selection, and facilitate a strategy of early empiric broad spectrum antibiotic coverage, with prompt de-escalation once antibiotic sensitivities are known. The effect of such an intervention, however, requires further study.
